Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Douai

9 clinical trials in Douai, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Douai at a glance
9
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Douai

Open in trial search
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lumateperone
  • Sponsor:Intra-Cellular Therapies Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:LYSERGIDE
  • Sponsor:Definium Therapeutics US Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aticaprant
  • Sponsor:Janssen - Cilag International
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gabapentin
  • Sponsor:Groupement Des Hopitaux De L'Institut Catholique De Lille

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Douai

What the registry says about research in the country

01 Mental Health Research

Innovative studies focusing on Major Depressive Disorder are evaluating new therapeutic approaches, including various adjunctive treatments to enhance the effectiveness of standard antidepressant therapy.

  • Depression Treatment Studies
  • Antidepressant Augmentation Trials
  • Long-term Safety Assessments

Multiple trials are investigating both short-term efficacy and long-term safety of novel compounds.

02 Anxiety Disorders

Research targeting Generalized Anxiety Disorder is exploring innovative therapeutic options through placebo-controlled studies, with particular attention to rapid-acting interventions.

  • Anxiety Symptom Management
  • Novel Treatment Approaches
  • Therapeutic Efficacy Studies

Clinical investigations are focused on developing more effective treatment options for anxiety management.

03 Pain Management & Critical Care

Studies addressing lumbosacral radiculalgia and critical conditions like septic shock are evaluating targeted therapeutic approaches. Additional research focuses on cardiac response in intensive care settings.

  • Acute Pain Management
  • Critical Care Interventions
  • Cardiovascular Response Studies

These trials aim to improve patient outcomes in both acute pain conditions and critical care scenarios.

04 Oncology Research

Advanced studies in breast cancer treatment are examining optimized hormone therapy protocols for post-menopausal women with specific tumor profiles.

  • Hormone Therapy Optimization
  • Low-Risk Cancer Management
  • Treatment Duration Studies

Research focuses on personalizing treatment durations while maintaining therapeutic efficacy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.